|
Volumn 2, Issue 6, 2011, Pages 433-434
|
Heat shock proteins and cancer therapy: The trail grows hotter!
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
GELDANAMYCIN;
HEAT SHOCK PROTEIN;
HEAT SHOCK PROTEIN 90;
PROTEIN P53;
PUROMYCIN;
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
PROTEASOME;
PYRAZINE DERIVATIVE;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER THERAPY;
CARCINOGENESIS;
CELL PROLIFERATION;
CELL TRANSFORMATION;
HEAT STRESS;
HEAT TOLERANCE;
HYPERTHERMIA;
INHIBITION KINETICS;
MOLECULAR MODEL;
MULTIPLE MYELOMA;
MUTATIONAL ANALYSIS;
NONHUMAN;
PHENOTYPIC VARIATION;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
PROTEIN FOLDING;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
PROTEIN SYNTHESIS INHIBITION;
TRANSCRIPTION INITIATION;
ANIMAL;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
NOTE;
PROTEOSTASIS DEFICIENCY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BORONIC ACIDS;
HUMANS;
MULTIPLE MYELOMA;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTEOSTASIS DEFICIENCIES;
PYRAZINES;
|
EID: 80555149868
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (6)
|